Trajectum Pharma Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

Trajectum Pharma General Information

Description

Developer of a tolerance-inducing cell therapy designed to treat autoimmune inflammatory diseases. The company's therapy is built on a deep-rooted understanding of immunologic functions in health and disease to develop an off-the-shelf vaccine for RA or possibly use CAR-T cells to induce tolerance, enabling physicians to treat autoimmune inflammatory diseases in an enhanced way.

Contact Information

Website
www.trajectumpharma.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • PO Box 85459
  • 3508 AL Utrecht
  • Netherlands
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • PO Box 85459
  • 3508 AL Utrecht
  • Netherlands

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Trajectum Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private Completed Generating Revenue
4. Seed Round 01-Jan-2020 Completed Generating Revenue
3. Seed Round 01-Jul-2010 Completed Generating Revenue
2. Grant 01-Jun-2010 $31.3K Completed Generating Revenue
1. University Spin-Out 01-Jan-2010 Completed Startup
To view Trajectum Pharma’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Trajectum Pharma Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Utrecht Holdings Not-For-Profit Venture Capital Minority
Utrecht University University
To view Trajectum Pharma’s complete investors history, request access »

Ready to get started?

Request a free trial

Trajectum Pharma FAQs

  • When was Trajectum Pharma founded?

    Trajectum Pharma was founded in 2010.

  • Where is Trajectum Pharma headquartered?

    Trajectum Pharma is headquartered in Utrecht, Netherlands.

  • What industry is Trajectum Pharma in?

    Trajectum Pharma’s primary industry is Drug Discovery.

  • Is Trajectum Pharma a private or public company?

    Trajectum Pharma is a Private company.

  • What is Trajectum Pharma’s current revenue?

    The current revenue for Trajectum Pharma is .

  • How much funding has Trajectum Pharma raised over time?

    Trajectum Pharma has raised $136K.

  • Who are Trajectum Pharma’s investors?

    Utrecht Holdings and Utrecht University have invested in Trajectum Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »